For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.
Price · 180d
$9.43
Thesis
Telix Pharmaceuticals is a commercial radiopharmaceutical company built on an approved prostate cancer imaging agent. Diagnostic revenue funds a broadening therapeutic radioligand pipeline across oncology.
Catalysts
- Illuccix commercial growth
- Kidney and additional diagnostic approvals
- Therapeutic radioligand program advancement